Perdomo-Lara SJ, Buenahora MR, Álvarez E, González-Martínez F, Rebolledo M, Aristizabal FA, et al. Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study. Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25 (1):e61-70.

doi:10.4317/medoral.23188

http://dx.doi.org/doi:10.4317/medoral.23188

1. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201. https://doi.org/10.1093/jnci/djs491 PMid:23297039 PMCid:PMC3565628

2. Grulich AE, JIN F, Conway EL, Stein AN, Hocking J. Cancers attributable to human papillomavirus infection. Sex Health. 2010;7:244-52. https://doi.org/10.1071/SH10020 PMid:20719211

3. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258-61.

4. Jiang S, Dong Y. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. Curr Probl Cancer. 2017;41:323-27. https://doi.org/10.1016/j.currproblcancer.2017.02.006 PMid:28416242

5. de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664-70. https://doi.org/10.1002/ijc.30716 PMid:28369882 PMCid:PMC5520228

6. Hübbers CU, Akgül B. HPV and cancer of the oral cavity. Virulence. 2015;6:244-8. https://doi.org/10.1080/21505594.2014.999570 PMid:25654476 PMCid:PMC4601238

7. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263-9. https://doi.org/10.1086/597755 PMid:19320589 PMCid:PMC4703086

8. Cook RL, Thompson EL, Kelso NE, et al. Sexual behaviors and other risk factors for oral human papillomavirus infections in young women. Sex Transm Dis. 2014;41:486-92. https://doi.org/10.1097/OLQ.0000000000000159 PMid:25013976 PMCid:PMC5528151

9. Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One. 2014;9:e91761. https://doi.org/10.1371/journal.pone.0091761 PMid:24637512 PMCid:PMC3956721

10. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006; 110:525-41. https://doi.org/10.1042/CS20050369 PMid:16597322

11. Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O, Falaschini S, et al. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol. 2007;30:813-23. https://doi.org/10.3892/ijo.30.4.813 PMid:17332919

12. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 1995;9:2335-49. https://doi.org/10.1101/gad.9.19.2335 PMid:7557386

13. Izumo T. Oral premalignant lesions: from the pathological viewpoint. Int J Clin Oncol. 2011;16:15-26. https://doi.org/10.1007/s10147-010-0169-z PMid:21234636

14. Sarode SC, Sarode GS, Karmarkar S, Tupkari JV. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol. 2011;47:920-1. https://doi.org/10.1016/j.oraloncology.2011.06.005 PMid:21715215

15. Ramya AS, Majumdar S, Babu TM, Uppala D, Srinivas B, Rao AK. Expression of Human Papillomavirus DNA and p53 Polymorphisms through Polymerase Chain Reaction in Normal Mucosa and Oral Leukoplakia Individuals with Deleterious Oral Habits. Int J Appl Basic Med Res. 2017;7:134-8. https://doi.org/10.4103/ijabmr.IJABMR_57_16 PMid:28584747 PMCid:PMC5441263

16. Ma J, Zhang J, Zhang Y, Lv T, Liu J. The Magnitude of the Association between Human Papillomavirus and Oral Lichen Planus: A Meta-Analysis. PLoS One. 2016;11:e0161339. https://doi.org/10.1371/journal.pone.0161339 PMid:27571417 PMCid:PMC5003373

17. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-9. https://doi.org/10.1016/j.virol.2010.02.002 PMid:20206957 PMCid:PMC3400342

18. Szentirmay Z, Polus K, Tamas L, et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev. 2005; 24:19-34. https://doi.org/10.1007/s10555-005-5045-3 PMid:15785870

19. Jayaprakash V, Reid M, Hatton E, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol. 2011;47:1048-54. https://doi.org/10.1016/j.oraloncology.2011.07.009 PMid:21816661 PMCid:PMC3640331

20. Syrjänen S, Lodi G, von Bültzingslöwen I, Aliko A, Arduino P, Campisi G, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011; 17 Suppl 1:58-72. https://doi.org/10.1111/j.1601-0825.2011.01792.x PMid:21382139

21. Hormia M, Willberg J, Ruokonen H, Syrjänen S. Marginal periodontium as a potential reservoir of human papillomavirus in oral mucosa. J Periodontol. 2005;76:58-63. https://doi.org/10.1902/jop.2005.76.3.358 PMid:15857068

22. Jimenez C, Correnti M, Salma N, Cavazza ME, Perrone M. Detection of human papillomavirus DNA in benign oral squamous epithelial lesions in Venezuela. J Oral Pathol Med. 2001;30:385-88. https://doi.org/10.1034/j.1600-0714.2001.300701.x PMid:11488414

23. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of Papillomaviruses. Virology. 2004;324:17-27. https://doi.org/10.1016/j.virol.2004.03.033 PMid:15183049

24. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-9. https://doi.org/10.1016/j.virol.2010.02.002 PMid:20206957 PMCid:PMC3400342

25. Zubach V, Smart G, Ratnam S, Severini A. Novel microsphere-based method for detection and typing of 46 mucosal human papillomavirus types. J Clin Microbiol. 2012;50:460-4. https://doi.org/10.1128/JCM.06090-11 PMid:22116162 PMCid:PMC3264170

26. Álvarez GJ, Álvarez E, Jiménez R, Mosquera Y, Gaviria AM, Garcés A, et al. Reverse smokers's and changes in oral mucosa. Department of Sucre, Colombia. Med Oral Patol Oral Cir Bucal. 2008;13:E1-8.

27. Huang CG, Lee LA, Liao CT, Yen TC, Yang SL, Liu YC, et al. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma. Oncotarget. 2017;8:34820-35. https://doi.org/10.18632/oncotarget.16747 PMid:28422732 PMCid:PMC5471014

28. Spector ME, Sacco AG, Bellile E, et al. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma. Clin Cancer Res. 2017;23:2723-9. https://doi.org/10.1158/1078-0432.CCR-16-1617 PMid:27872102 PMCid:PMC5438906

29. Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O, et al. Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort. PLoS One. 2019;14:e0210070. https://doi.org/10.1371/journal.pone.0210070 PMid:30650110 PMCid:PMC6335078

30. Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, Senguven B, McConkey C, Rabbitts P, Mehanna H. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia. J Oral Pathol Med. 2014;43:245-9. https://doi.org/10.1111/jop.12128 PMid:24372672

31. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108:djv403.

32. Chen X1, Zhao Y2. Human papillomavirus infection in oral potentially malignant disorders and cancer. Arch Oral Biol. 2017;83:334-9. https://doi.org/10.1016/j.archoralbio.2017.08.011 PMid:28886585

33.Tam S, Fu S, Xu L, Krause KJ, et al. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018;82:91-9. https://doi.org/10.1016/j.oraloncology.2018.04.005 PMid:29909908

34. Mohammed KA, Subramaniam DS, Geneus CJ, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39-43. https://doi.org/10.1016/j.ypmed.2018.01.016 PMid:29378268

35. Bui TC, Tran LT, Thai TN, Shete SS, Vidrine DJ, Sturgis EM. Prevalence of and Risk Factors for Oral Human Papillomavirus Infection with Multiple Genotypes in the United States. Sex Transm Dis. 2017;44:166-72.

36. Akhondnezhad M, Haghshenas MR, Ghasemi M, Mousavi T. The prevalence and genotyping of human papillomavirus in patients with oral tumors in health centers and clinics of Mazandaran in Iran. Virusdisease. 2018;29:297-302. https://doi.org/10.1007/s13337-018-0472-2 PMid:30159363 PMCid:PMC6111957

37. Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, et al,. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer. 2017;140:1968-75. https://doi.org/10.1002/ijc.30608 PMid:28108990

38. Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O et al. Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanishcohort. PLoS One. 2019;14:e0210070. https://doi.org/10.1371/journal.pone.0210070 PMid:30650110 PMCid:PMC6335078